RedHill Biopharma Ltd. (RDHL) stock
RDHLNasdaqPharmaceutical Preparations
$0.38−0.01 (-1.60%)
Close on Nov 13, 2026Market cap $1.91MP/E –Yield –
RedHill Biopharma total assets
Total assets on the balance sheet at the end of each period.
RedHill Biopharma's total assets was $26.27M at Jun 30, 2026. For fiscal 2025 it was $25.35M, up 40.5% from the year before. The highest annual figure on record is $181.19M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $25.35M | +40.5% |
| FY2024 | Dec 31, 2024 | $18.04M | -21.7% |
| FY2023 | Dec 31, 2023 | $23.05M | -85.5% |
| FY2022 | Dec 31, 2022 | $158.87M | -12.3% |
| FY2021 | Dec 31, 2021 | $181.19M | +0.5% |
| FY2020 | Dec 31, 2020 | $180.24M | +143.2% |
| FY2019 | Dec 31, 2019 | $74.10M | +18.7% |
| FY2018 | Dec 31, 2018 | $62.41M | +8.8% |
| FY2017 | Dec 31, 2017 | $57.34M | -22.7% |
| FY2016 | Dec 31, 2016 | $74.21M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $26.27M | +19.3% |
| Q4 FY2025 | Dec 31, 2025 | $25.35M | +10.0% |
| Q2 FY2025 | Jun 30, 2025 | $18.38M | -47.6% |
| Q4 FY2024 | Dec 31, 2024 | $18.04M | -88.6% |
| Q2 FY2024 | Jun 30, 2024 | $22.02M | -86.9% |
| Q4 FY2023 | Dec 31, 2023 | $23.05M | -87.3% |
| Q2 FY2023 | Jun 30, 2023 | $35.04M | -82.8% |
| Q4 FY2022 | Dec 31, 2022 | $158.87M | -11.9% |
| Q2 FY2022 | Jun 30, 2022 | $167.97M | +1.0% |
| Q4 FY2021 | Dec 31, 2021 | $181.19M | +144.5% |
| Q2 FY2021 | Jun 30, 2021 | $203.67M | +309.8% |
| Q4 FY2020 | Dec 31, 2020 | $180.24M | +188.8% |
| Q2 FY2020 | Jun 30, 2020 | $166.37M | +339.6% |
| Q4 FY2019 | Dec 31, 2019 | $74.10M | +29.2% |
| Q2 FY2019 | Jun 30, 2019 | $49.70M | -33.0% |
| Q4 FY2018 | Dec 31, 2018 | $62.41M | – |
| Q2 FY2018 | Jun 30, 2018 | $37.85M | – |
| Q4 FY2017 | Dec 31, 2017 | $57.34M | – |
| Q4 FY2016 | Dec 31, 2016 | $74.21M | – |
See a number that looks wrong?